A direct Pharmacological activation of mTORC1 in combination with proteasome inhibitors is an efficient therapy for acute myeloid leukemia
收藏NIAID Data Ecosystem2026-05-02 收录
官方服务：
资源简介：
Purposing of proteasome inhibitors for AML by a novel mTOR-inducing new drug AcTor
创建时间：
2025-03-14
